ACLARION, INC. (ACON) Gross Margin
- Gross margin · 12 months: Value 21.76%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 21.76% | Gross profit / revenue. Period ending 2026-06-30. $18.22K ÷ $83.77K × 100 ≈ 21.76% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 18.22K USD | Gross Profit |
| Revenue | 83.77K USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $18.22K | $83.77K | (m) | 21.76% |
| 2026-03-31 | $15.07K | $77.88K | (m) | 19.35% |
| 2025-12-31 | $6.83K | $75.73K | (m) | 9.02% |
| 2025-09-30 | $-5.29K | $67.48K | (m) | -7.83% |
| 2025-06-30 | $-16.60K | $62.95K | (m) | -26.37% |
| 2025-03-31 | $-34.06K | $54.60K | (m) | -62.38% |
| 2024-12-31 | $-38.93K | $45.72K | (m) | -85.15% |
| 2024-09-30 | $-34.23K | $49.29K | (m) | -69.45% |
| 2024-06-30 | $-27.80K | $53.95K | (m) | -51.53% |
| 2024-03-31 | $-17.70K | $60.05K | (m) | -29.48% |
| 2023-12-31 | $-324.00 | $75.40K | (m) | -0.43% |
| 2023-09-30 | $10.53K | $84.13K | (m) | 12.51% |
| 2023-06-30 | $12.21K | $83.28K | (m) | 14.66% |
| 2023-03-31 | $10.87K | $76.89K | (m) | 14.14% |
| 2022-12-31 | $-4.85K | $60.44K | (m) | -8.03% |
| 2022-09-30 | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-8.88K | $60.29K | (m) | -14.73% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |